Defining the impact of shift work on autoimmunity and autoimmune disease development in systemic lupus erythematosus (SLE)

Background:

The circadian rhythm is an evolutionarily conserved adaptation that influences nearly every process in the body and is coordinated by the suprachiasmatic nucleus, with peripheral clocks present in almost every tissue, including the immune system. Circadian rhythm and immune function are bidirectionally linked, for example: clock genes influence immune cell activation, cytokine production, and lymphocyte trafficking, while inflammatory signals in turn feed back on clock gene expression. Studies on insomnia and shift work have reported elevated autoantibody levels, and circadian disruption has recently been shown to correlate with disease progression in autoimmune conditions such as autoimmune thyroiditis and rheumatoid arthritis, as well as with disease development in metabolic disorders such as type 2 diabetes. We therefore hypothesize that circadian disruption triggers systemic chronic inflammation and predisease flares by promoting a pro-inflammatory environment and dysregulating T-cell trafficking and function.
However, because autoimmune diseases are typically screened for only after diagnosis, and because impaired sleep is usually self-treated rather than medically documented, the temporal relationship between circadian disruption and the predisease phase of autoimmunity remains largely unresolved. It is difficult to dissect whether circadian disruption drives autoimmunity or whether the predisease phase itself disrupts the circadian system. This project addresses precisely this gap by longitudinally monitoring both immune and circadian parameters in the predisease phase of SLE-prone mice.

Objectives:

I) Investigating whether simulated shift work accelerates disease onset and progression of systemic lupus erythematosus (SLE)
II) Monitoring SLE progression longitudinally via ANA titers in blood and proteinuria as a marker of kidney inflammation
III) Profiling candidate markers in spleen, lymph nodes, kidney, blood, and urine
IV) Distinguishing stable from dynamic predisease changes by assessing markers at regular intervals before and after expected disease onset

 

Work program:

Investigation of disease progression in NZBWF1/J mice and controls, covering the entire time course of SLE development (weeks 8–40). Mice will be housed under inverted light schedules to simulate night-shift work. These schedules will be maintained until the end of the experiment. To evaluate the influence of circadian disruption on SLE development, groups of mice will be euthanized at 8, 16, 24, 32, and 40 weeks of age. Blood and organs will be analyzed to identify longitudinal changes in inflammatory markers, ANA titers and lymphocyte populations via flow cytometry, qPCR, immunofluorescence staining of tissue and microscopy.